Surely patients in a just society should not be penalized for having a genetic predisposition to a potentially fatal disease.The claim also pointed to guidelines from the American Association for the Study of Liver Disease which similarly question the six-month sober rule, noting that transplant rejection and survival rates are similar between recipients with alcohol related disease and other recipients. After initially vigorously fighting Debra’s challenge, lawyers for the province approached her last May and convinced her to put her case on hold while transplant listing criteria were reviewed. The lawyers admitted that the research Debra presented “did not necessarily bolster their position”. Debra ended up pulling out of the agreement she made with the lawyers after a series of delay and backtracks. However, in the meantime, Trillium agreed to the pilot project.
I’m very proud that up to 97 or 98 people will get the opportunity to have a new life…nd I’m very hopeful the practice will continue.This pilot project will likely have a deep impact on patients with alcohol related liver disease. Currently, approximately 2,800 Canadians with alcoholic liver disease die annually. This project may decrease those numbers. We will continue to follow developments in this matter, and will provide updates as they become available. At Wise Health Law, we provide exceptional guidance on health law matters to public hospitals and other health-care organizations across the province. We monitor trends and developments in health care, medicine, and health law so that we can provide forward-thinking legal and risk management advice to each of our clients. Contact us online, or at 416-915-4234 for a consultation.
The Chief Medical Officer of Health for Ontario has issued an updated Directive #2 (dated May 26, 2020) for Regulated Health Professionals in the province.
Pursuant to the updated Directive #2, all deferred non-essential and elective services by health care providers may be gradually restarted – subject to the rest of the requirements set out in the Directive.
The updated Directive #2 does not provide particularly detailed guidance to health professionals on how to proceed, likely because it applies to such a broad spectrum of health care and health professionals. It does, however, provide some principles to assist health care providers in making decisions as we enter this transitional period.
In addition to the mask and hand sanitizer shortages, Ontario’s response to COVID-19 highlights the need for more frontline health care workers. Each regulated health profession’s college responded differently, and we have discussed some of those changes in other posts to keep you apprised.
Today, we focus on the College of Physicians and Surgeons of Ontario (CPSO), who set out to increase the number of available and licenced physicians out on the frontlines through certificates of registration that authorize supervised practice of short duration. The temporary licences authorize practice for 30 days.
Undoubtedly, COVID-19 has affected how health professionals practice. Pharmacists across the country are not only experiencing changes in how they practice (for example, accepting emailed prescriptions, where appropriate) but the scope of their practice as well. The latter change is not permanent, although the disruptions in practice may be felt long after the COVID-19 emergency subsides.
On March 19, 2020, Health Canada issued a short-term section 56(1) exemption under the Controlled Drugs and Substances Act (CDSA) that would authorize pharmacists to prescribe, sell, or provide controlled substances in limited circumstances, or transfer prescriptions for controlled substances (the CDSA Exemption).